MEN1 and prostate cancer: Notably, Bourefis et al. found that using a combination of HSP27 and menin serum levels was more accurate for predicting prostate cancer aggressiveness and mortality than PSA [331], suggesting that high serum menin levels may be useful for identifying individuals with prostate cancer who may be at increased risk for aggressive disease and mortality.